Detalhe da pesquisa
1.
Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report.
Medicine (Baltimore)
; 99(8): e18889, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32080073
2.
Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN® in combination with chemotherapy.
Future Sci OA
; 5(10): FSO435, 2019 Oct 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31827897